Federation Bio News Today

The University of Texas MD Anderson Cancer Center and Federation Bio today announced a strategic collaboration to design and manufacture a complex, synthetic microbial consortium with the goal of expanding the number of cancer patients who respond to immunotherapy.

/PRNewswire/ -- The University of Texas MD Anderson Cancer Center and Federation Bio, a biotechnology company pioneering bacterial cell therapies, today...

/PRNewswire/ -- Federation Bio, a biotechnology company pioneering bacterial cell therapies, today announced that investigators have administered the first...

/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...

/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a biotechnology company creating precisely targeted therapies for clinically proven kinase targets in cancer,...

/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a biotechnology company creating precisely targeted therapies for clinically proven kinase targets in cancer,...

GlaxoSmithKline poached Pfizer's RNA and viral vaccines leader Phil Dormitzer, M.D., Ph.D., to shore up its vaccine business as it's lost many research staffers this past year. Parthenon Therapeutics snagged Johnson & Johnson's global head of cell therapy platform and discovery, Tamas Oravecz, Ph.D. And Rafael parted ways with five execs and reinstalled telecom tycoon Howard Jonas as CEO.

/PRNewswire/ -- Federation Bio, a biotechnology company pioneering engineered bacterial cell therapies, today announced the appointment of two new members to...

/PRNewswire/ -- Federation Bio, a biotechnology company pioneering engineered bacterial cell therapies, today announced the appointment of two new members to...

Insider scoured startups, venture creation firms and accelerators to find the young founders creating scores of biotechs.